A patient is prescribed a calcium channel blocker, develops ankle swelling, and is then prescribed a diuretic without anyone reconsidering the first drug. This best illustrates:
Choose an answer, then check it.
Clinical Pharmacology · Special Populations
Polypharmacy
On this page 6 sections
In 30 seconds
Polypharmacy means taking many medications at once, but the number alone tells you little. The useful distinction is appropriate polypharmacy, where multiple diseases genuinely require multiple drugs, versus problematic polypharmacy, where drugs are unindicated, duplicated, or now carry more risk than benefit. Interaction risk rises faster than the drug count because each addition multiplies against every drug already present. The pattern to recognize above all others is the prescribing cascade, where a drug's side effect is mistaken for a new disease and treated with another drug instead of being stopped.
The college version
Appropriate versus problematic polypharmacy
A person with heart failure, diabetes, and atrial fibrillation may reasonably take a diuretic, a beta-blocker, an ACE inhibitor, an anticoagulant, and a glucose-lowering agent — many drugs, but each with a clear indication: appropriate polypharmacy. Problematic polypharmacy looks different: a drug started for a problem that resolved and never stopped, two drugs from the same class doing the same job, or a drug whose risk-benefit balance has shifted with age or new diagnoses. The fix is not fewer pills but matching every drug to a current, valid reason for that patient.
Why risk rises disproportionately
Each added drug multiplies possible interactions with every drug already on the list rather than simply adding its own risk: a two-drug regimen has one possible pairwise interaction, a five-drug regimen has ten, a ten-drug regimen has forty-five. Drugs also compete for shared metabolic pathways and organs, so the burden compounds nonlinearly, hitting older adults and those with reduced renal or hepatic reserve hardest.
The prescribing cascade
The prescribing cascade is the central mechanism to recognize: a drug causes an adverse effect, that effect is misread as a new medical condition, and a second drug is prescribed to treat it — when reducing or stopping the first drug was correct. Classic patterns: a calcium channel blocker causes ankle edema, prompting a diuretic instead of a dose change; an anticholinergic drug causes urinary retention, prompting a second drug aimed at that "new" symptom instead of reconsidering the anticholinergic. Each cascade adds a drug, and each added drug can trigger another.
Categories of drug interaction
Interactions are pharmacokinetic or pharmacodynamic. Pharmacokinetic interactions occur at absorption, distribution, metabolism, or excretion — one drug changes how much of another reaches its target or how fast it clears. Pharmacodynamic interactions occur when drugs combine at the site of effect regardless of blood levels — additive, synergistic, or antagonistic. High-yield examples: additive anticholinergic burden causing confusion and retention; additive sedation from stacked CNS depressants; additive QT prolongation from multiple QT-prolonging drugs; additive bleeding risk from overlapping anticoagulants; and serotonin syndrome from combined serotonergic drugs, causing agitation and autonomic instability.
Hidden contributors
Medication lists are frequently incomplete. Over-the-counter analgesics and sleep aids, supplements, and herbal products such as St. John's wort — an enzyme inducer that can lower levels of many prescribed drugs — rarely appear on a chart unless asked about. Care fragmented across multiple prescribers without a shared list is another contributor: each clinician may treat one problem in isolation, unaware of what others have prescribed.
Deprescribing as a structured skill
Deprescribing is the deliberate process of reducing or stopping medications no longer beneficial or now riskier than helpful: take a complete medication history including nonprescription products; identify drugs lacking a current indication; prioritize which to address first by risk; taper rather than stop abruptly when withdrawal is a concern; change one medication at a time; monitor closely; and involve the patient in decisions about goals of care, especially when life expectancy and treatment burden matter. Clinicians use explicit criteria lists and interaction checkers to flag risky combinations, though clinical judgment remains central. Nurses reconcile medication lists at every transition of care, ask about supplements and OTC use, and flag discrepancies before they cause harm.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine a backpack where every day someone adds one more item "just in case," but nobody ever takes anything out. Some items truly belong — lunch, water, a jacket for real weather — and the bag stays sensible as long as everything in it has a job. Trouble starts when things pile up that no longer make sense: a broken toy, three copies of the same snack, or something added only because another item was scratchy. That last one is the prescribing cascade — instead of removing the scratchy item, someone adds padding to cover it up, making the bag heavier and more confusing. The more items in the bag, the more they bump into each other and the more likely something spills. Cleaning out that backpack, one item at a time, checking what's actually still needed, is what deprescribing does with medications.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient's chart lists five prescription medications, but a nurse learns during a thorough history that the patient also regularly takes an herbal supplement and an over-the-counter sleep aid. Why does this matter for polypharmacy risk?
Show answer
Hidden products count too, and can interact just as seriously as prescription drugs.
Herbal supplements and OTC products often go unmentioned unless asked about directly, yet an herbal supplement can change how other drugs are processed and a sleep aid can add to sedation — both raising real risk beyond the visible prescription list.
A clinician wants to begin deprescribing for a patient on many medications with limited life expectancy. Describe two structured steps that should guide this process.
Show answer
Prioritize which drugs to address first by risk, and change one medication at a time while monitoring closely.
Sensible steps also include tapering instead of stopping abruptly when withdrawal is a concern, and involving the patient in decisions about goals of care so the process reflects what matters most for their comfort.
Quick check
3 questions here. Answers stay hidden until you check.
Which best distinguishes appropriate polypharmacy from problematic polypharmacy?
Choose an answer, then check it.
Combining several sedating medications, several anticholinergic drugs, or several serotonergic drugs is a concern primarily because of which interaction type?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.